PPARG and Huntington disease: Earlier studies reported downregulation of PPARγ in the striatum and peripheral tissues of HD transgenic animals [14] and mutant huntingtin (mHTT)-expressing striatal cells [17], suggesting that PPARγ-activating drugs could protect striatal cells from the mHTT-induced energy deficit.